VIR Stock Analysis: Buy, Sell, or Hold?
VIR - Vir Biotechnology, Inc. Common Stock
$8.90
0.24 (2.77%)
▲
5d:
+1.14%
30d:
-11.35%
90d:
-11.0%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
1d
Get Alerted When VIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VIR shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: VIR shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: VIR is currently trading at $8.90, which is considered oversold relative to its 30-day fair value range of $9.22 to $10.18.
Technical Outlook: Technically, VIR is in a downtrend. Immediate support is located at $8.52, while resistance sits at $9.59.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.56 (+142.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VIR is in a downtrend. Immediate support is located at $8.52, while resistance sits at $9.59.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.56 (+142.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.22 -
$10.18
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 142.2% below Wall St target ($21.56)
Trading Range Analysis
30-Day Trading Range
$9.22 -
$10.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$8.52
Resistance Level
$9.59
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.83
Wall Street Target
$21.56
(+142.2%)
Revenue Growth (YoY)
417.8%
Earnings Growth (YoY)
58.5%
Share & Embed Analysis
Last updated: August 03, 2026 6:11 PM ET
Data refreshes hourly during market hours. Next update: 7:11 PM
Data refreshes hourly during market hours. Next update: 7:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
Backer Marianne De
SELL
72559 shares
2026-04-06
Vicki L Sato
SELL
22000 shares
2026-04-01
Brent Sabatini
SELL
7711 shares
2026-03-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1080 | 57 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 54 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
